Bridget E. Bunner

Array ( [id] => 7669078 [patent_doc_number] => 20110318347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'AMINO ACID SEQUENCES TARGETING HUMAN CD4, CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN, BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY' [patent_app_type] => utility [patent_app_number] => 13/124001 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 131477 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479101 [patent_doc_number] => 20100092462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Methods for Suppressing Toll-Like Receptor Activity' [patent_app_type] => utility [patent_app_number] => 12/572338 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9264 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092462.pdf [firstpage_image] =>[orig_patent_app_number] => 12572338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6372767 [patent_doc_number] => 20100080808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'ANTI-NOTCH2 ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/570267 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 51058 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080808.pdf [firstpage_image] =>[orig_patent_app_number] => 12570267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427340 [patent_doc_number] => 08703413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Detection of human somatic cell reprogramming' [patent_app_type] => utility [patent_app_number] => 13/120192 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 12852 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8213472 [patent_doc_number] => 08192738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Targeted antibodies directed to DLL4' [patent_app_type] => utility [patent_app_number] => 12/562268 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 94131 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/192/08192738.pdf [firstpage_image] =>[orig_patent_app_number] => 12562268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579752 [patent_doc_number] => 20110293635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'COMPOSITION AND METHODS FOR MODULATING TOLL-LIKE RECEPTOR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/119116 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22379 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293635.pdf [firstpage_image] =>[orig_patent_app_number] => 13119116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4612744 [patent_doc_number] => 07989208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Gamma secretase notch biomarkers' [patent_app_type] => utility [patent_app_number] => 12/552361 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9079 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989208.pdf [firstpage_image] =>[orig_patent_app_number] => 12552361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090351 [patent_doc_number] => 20110218146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'ADIPONECTIN FOR TREATING PULMONARY DISEASE' [patent_app_type] => utility [patent_app_number] => 13/060422 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9362 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218146.pdf [firstpage_image] =>[orig_patent_app_number] => 13060422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014900 [patent_doc_number] => 20110223183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'HUMAN NOTCH3 BASED FUSION PROTEINS AS DECOY INHIBITORS OF NOTCH3 SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/060254 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 20088 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212351 [patent_doc_number] => 20110135651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'METHOD AND COMPOSITION FOR ENHANCING HEMATOPOIETIC STEM CELL MOBILIZATION' [patent_app_type] => utility [patent_app_number] => 13/057458 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6308 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135651.pdf [firstpage_image] =>[orig_patent_app_number] => 13057458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494066 [patent_doc_number] => 20100009918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHOD FOR THE ADMINISTRATION OF LIGANDS, AGONISTS OF LIGANDS OF THE TNF FAMILY WITH REDUCED TOXICITY' [patent_app_type] => utility [patent_app_number] => 12/542183 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5571 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009918.pdf [firstpage_image] =>[orig_patent_app_number] => 12542183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477666 [patent_doc_number] => 20100041608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'METHOD FOR STIMULATING WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 12/538714 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6326 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041608.pdf [firstpage_image] =>[orig_patent_app_number] => 12538714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9523908 [patent_doc_number] => 08748170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Polypeptides derived from cyclin B1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/055907 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 2 [patent_no_of_words] => 3945 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398213 [patent_doc_number] => 08268592 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Anti-system ASC amino acid transporter 2 (ASCT2) antibody' [patent_app_type] => utility [patent_app_number] => 12/505133 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 50808 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12505133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958464 [patent_doc_number] => 20110182851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'OXIDIZED LDL SPECIFIC ANTIBODY-FUSION AND CONJUGATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/003648 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3551 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182851.pdf [firstpage_image] =>[orig_patent_app_number] => 13003648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662283 [patent_doc_number] => 20110311552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'NOTCH1 RECEPTOR BINDING AGENTS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/003013 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33841 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311552.pdf [firstpage_image] =>[orig_patent_app_number] => 13003013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314244 [patent_doc_number] => 20100111958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Notch-Binding Agents and Antagonists and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/499627 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 54826 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111958.pdf [firstpage_image] =>[orig_patent_app_number] => 12499627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972473 [patent_doc_number] => 20110152173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/001087 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 41179 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152173.pdf [firstpage_image] =>[orig_patent_app_number] => 13001087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12283216 [patent_doc_number] => 09931386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity [patent_app_type] => utility [patent_app_number] => 12/483876 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 101 [patent_no_of_words] => 22566 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12483876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710113 [patent_doc_number] => 20120003181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Novel Retinoid Inducible Factor and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/997034 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9958 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997034 [rel_patent_id] =>[rel_patent_doc_number] =>)